These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 31352904)
1. The long-term survival characteristics of a cohort of colorectal cancer patients and baseline variables associated with survival outcomes with or without time-varying effects. Yu Y; Carey M; Pollett W; Green J; Dicks E; Parfrey P; Yilmaz YE; Savas S BMC Med; 2019 Jul; 17(1):150. PubMed ID: 31352904 [TBL] [Abstract][Full Text] [Related]
2. Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer. Margonis GA; Buettner S; Andreatos N; Kim Y; Wagner D; Sasaki K; Beer A; Schwarz C; Løes IM; Smolle M; Kamphues C; He J; Pawlik TM; Kaczirek K; Poultsides G; Lønning PE; Cameron JL; Burkhart RA; Gerger A; Aucejo FN; Kreis ME; Wolfgang CL; Weiss MJ JAMA Surg; 2018 Jul; 153(7):e180996. PubMed ID: 29799910 [TBL] [Abstract][Full Text] [Related]
3. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency. Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842 [TBL] [Abstract][Full Text] [Related]
4. Relationships among Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081 [TBL] [Abstract][Full Text] [Related]
5. Poor prognosis of KRAS or BRAF mutant colorectal liver metastasis without microsatellite instability. Umeda Y; Nagasaka T; Mori Y; Sadamori H; Sun DS; Shinoura S; Yoshida R; Satoh D; Nobuoka D; Utsumi M; Yoshida K; Yagi T; Fujiwara T J Hepatobiliary Pancreat Sci; 2013 Feb; 20(2):223-33. PubMed ID: 23010994 [TBL] [Abstract][Full Text] [Related]
6. Microsatellite Alterations With Allelic Loss at 9p24.2 Signify Less-Aggressive Colorectal Cancer Metastasis. Koi M; Garcia M; Choi C; Kim HR; Koike J; Hemmi H; Nagasaka T; Okugawa Y; Toiyama Y; Kitajima T; Imaoka H; Kusunoki M; Chen YH; Mukherjee B; Boland CR; Carethers JM Gastroenterology; 2016 Apr; 150(4):944-55. PubMed ID: 26752111 [TBL] [Abstract][Full Text] [Related]
7. BRAF mutations in colorectal cancer are associated with distinct clinical characteristics and worse prognosis. Kalady MF; Dejulius KL; Sanchez JA; Jarrar A; Liu X; Manilich E; Skacel M; Church JM Dis Colon Rectum; 2012 Feb; 55(2):128-33. PubMed ID: 22228154 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of BRAF V600E mutation and microsatellite instability in Japanese patients with sporadic colorectal cancer. Nakaji Y; Oki E; Nakanishi R; Ando K; Sugiyama M; Nakashima Y; Yamashita N; Saeki H; Oda Y; Maehara Y J Cancer Res Clin Oncol; 2017 Jan; 143(1):151-160. PubMed ID: 27672042 [TBL] [Abstract][Full Text] [Related]
9. Role of the BRAF mutations in the microsatellite instability genetic pathway in sporadic colorectal cancer. Maestro ML; Vidaurreta M; Sanz-Casla MT; Rafael S; Veganzones S; Martínez A; Aguilera C; Herranz MD; Cerdán J; Arroyo M Ann Surg Oncol; 2007 Mar; 14(3):1229-36. PubMed ID: 17195912 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of Long-Term Outcomes of Microsatellite Instability Status in an Asian Cohort of Sporadic Colorectal Cancers. Tan WJ; Hamzah JL; Acharyya S; Foo FJ; Lim KH; Tan IBH; Tang CL; Chew MH J Gastrointest Cancer; 2018 Sep; 49(3):311-318. PubMed ID: 28550452 [TBL] [Abstract][Full Text] [Related]
11. Prediagnostic Physical Activity and Colorectal Cancer Survival: Overall and Stratified by Tumor Characteristics. Hardikar S; Newcomb PA; Campbell PT; Win AK; Lindor NM; Buchanan DD; Makar KW; Jenkins MA; Potter JD; Phipps AI Cancer Epidemiol Biomarkers Prev; 2015 Jul; 24(7):1130-7. PubMed ID: 25976417 [TBL] [Abstract][Full Text] [Related]
12. Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer. Seppälä TT; Böhm JP; Friman M; Lahtinen L; Väyrynen VM; Liipo TK; Ristimäki AP; Kairaluoma MV; Kellokumpu IH; Kuopio TH; Mecklin JP Br J Cancer; 2015 Jun; 112(12):1966-75. PubMed ID: 25973534 [TBL] [Abstract][Full Text] [Related]
13. Fusion Kinases Identified by Genomic Analyses of Sporadic Microsatellite Instability-High Colorectal Cancers. Sato K; Kawazu M; Yamamoto Y; Ueno T; Kojima S; Nagae G; Abe H; Soda M; Oga T; Kohsaka S; Sai E; Yamashita Y; Iinuma H; Fukayama M; Aburatani H; Watanabe T; Mano H Clin Cancer Res; 2019 Jan; 25(1):378-389. PubMed ID: 30279230 [TBL] [Abstract][Full Text] [Related]
14. [Impacts of microsatellite status, RAS and BRAF mutation on postoperative follow-up strategy in stage II( and III( colorectal cancer]. Zhang J; Wang X; Shen L Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jun; 21(6):716-720. PubMed ID: 29968248 [TBL] [Abstract][Full Text] [Related]
15. Influence of pre-diagnostic cigarette smoking on colorectal cancer survival: overall and by tumour molecular phenotype. Zhu Y; Yang SR; Wang PP; Savas S; Wish T; Zhao J; Green R; Woods M; Sun Z; Roebothan B; Squires J; Buehler S; Dicks E; Zhao J; Mclaughlin JR; Parfrey PS; Campbell PT Br J Cancer; 2014 Mar; 110(5):1359-66. PubMed ID: 24448365 [TBL] [Abstract][Full Text] [Related]
16. Microsatellite instability and DNA ploidy in colorectal cancer: potential implications for patients undergoing systematic surveillance after resection. Søreide K; Slewa A; Stokkeland PJ; van Diermen B; Janssen EA; Søreide JA; Baak JP; Kørner H Cancer; 2009 Jan; 115(2):271-82. PubMed ID: 19109816 [TBL] [Abstract][Full Text] [Related]
17. Microsatellite instability and B-type Raf proto-oncogene mutation in colorectal cancer: Clinicopathological characteristics and effects on survival. Batur S; Vuralli Bakkaloglu D; Kepil N; Erdamar S Bosn J Basic Med Sci; 2016 Nov; 16(4):254-260. PubMed ID: 27131021 [TBL] [Abstract][Full Text] [Related]
18. Combined microsatellite instability and BRAF gene status as biomarkers for adjuvant chemotherapy in stage III colorectal cancer. Ooki A; Akagi K; Yatsuoka T; Asayama M; Hara H; Takahashi A; Kakuta M; Nishimura Y; Yamaguchi K J Surg Oncol; 2014 Dec; 110(8):982-8. PubMed ID: 25154726 [TBL] [Abstract][Full Text] [Related]
19. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Mima K; Nishihara R; Qian ZR; Cao Y; Sukawa Y; Nowak JA; Yang J; Dou R; Masugi Y; Song M; Kostic AD; Giannakis M; Bullman S; Milner DA; Baba H; Giovannucci EL; Garraway LA; Freeman GJ; Dranoff G; Garrett WS; Huttenhower C; Meyerson M; Meyerhardt JA; Chan AT; Fuchs CS; Ogino S Gut; 2016 Dec; 65(12):1973-1980. PubMed ID: 26311717 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic features of synchronous colorectal carcinoma: A distinct subset arising from multiple sessile serrated adenomas and associated with high levels of microsatellite instability and favorable prognosis. Hu H; Chang DT; Nikiforova MN; Kuan SF; Pai RK Am J Surg Pathol; 2013 Nov; 37(11):1660-70. PubMed ID: 23887157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]